IFNα Subtypes in HIV Infection and Immunity

Zehra Karakoese,Martha Ingola,Barbara Sitek,Ulf Dittmer,Kathrin Sutter

DOI: https://doi.org/10.3390/v16030364

2024-02-28

Viruses

Abstract:Type I interferons (IFN), immediately triggered following most viral infections, play a pivotal role in direct antiviral immunity and act as a bridge between innate and adaptive immune responses. However, numerous viruses have evolved evasion strategies against IFN responses, prompting the exploration of therapeutic alternatives for viral infections. Within the type I IFN family, 12 IFNα subtypes exist, all binding to the same receptor but displaying significant variations in their biological activities. Currently, clinical treatments for chronic virus infections predominantly rely on a single IFNα subtype (IFNα2a/b). However, the efficacy of this therapeutic treatment is relatively limited, particularly in the context of Human Immunodeficiency Virus (HIV) infection. Recent investigations have delved into alternative IFNα subtypes, identifying certain subtypes as highly potent, and their antiviral and immunomodulatory properties have been extensively characterized. This review consolidates recent findings on the roles of individual IFNα subtypes during HIV and Simian Immunodeficiency Virus (SIV) infections. It encompasses their induction in the context of HIV/SIV infection, their antiretroviral activity, and the diverse regulation of the immune response against HIV by distinct IFNα subtypes. These insights may pave the way for innovative strategies in HIV cure or functional cure studies.

virology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is about the role of type I interferon (IFN), especially the IFN - α subtype, in human immunodeficiency virus (HIV) infection and immune response. Specifically, the research focuses on the following aspects:

1. **Induction of IFN - α subtypes**: Explore how the expression of different IFN - α subtypes is induced during HIV or simian immunodeficiency virus (SIV) infection. This includes pattern - recognition receptors (PRRs) that recognize HIV replication intermediates, such as TLR7/8, cGAS, DDX3 and RIG - I, and how these receptors trigger downstream signaling pathways, ultimately leading to the production of IFN - α subtypes.

2. **Antiretroviral activity**: Evaluate the antiviral ability of different IFN - α subtypes against HIV. Research shows that some IFN - α subtypes (such as IFN - α14, IFN - α6, IFN - α17 and IFN - α21) exhibit strong antiviral activity and can significantly inhibit HIV replication.

3. **Immunomodulatory effects**: Analyze how different IFN - α subtypes regulate innate and adaptive immune responses. IFN - α subtypes not only act through direct antiviral mechanisms, but also enhance the host's defense ability by activating immune cells and regulating immune responses.

4. **Clinical treatment potential**: Explore the potential applications of different IFN - α subtypes in HIV treatment. Currently, clinical treatment mainly relies on a single IFN - α subtype (such as IFN - α2a/b), but its efficacy is limited. The research has found that some IFN - α subtypes may have higher treatment potential, providing a theoretical basis for the development of new HIV treatment strategies.

Through these studies, the paper aims to provide new ideas and methods for the cure or functional cure of HIV.